» Articles » PMID: 39407169

Risk Factors of Severe Postpartum Hemorrhage in Pregnant Women with Placenta Previa or Low-lying Placenta: a Retrospective Cohort Study

Overview
Publisher Biomed Central
Date 2024 Oct 15
PMID 39407169
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The severe postpartum hemorrhage (SPPH) leads to dangerous maternal conditions, and its rate is still increasing and the trend in related risk factors is changing. Placenta-related problems remain the high-risk factor for SPPH. The object is to investigate the prevalence and the risk factors of the severe postpartum hemorrhage in pregnant women with placenta previa or low-lying placenta.

Method: A retrospective analysis of pregnant women with placenta previa or low-lying placenta after 28 weeks gestation from May 2018 to May 2023 in the Peking Union Medical College Hospital was conducted. The primary outcome was severe postpartum hemorrhage defined as blood loss ≥ 1000 mL within 24 h of childbirth, or with signs or symptoms of low blood volume requiring transfusion of ≥ 4U of red blood cells. Univariate and multivariate logistic regression were used to identify potential risk factors of severe postpartum hemorrhage and receiver operating curve to evaluate the prediction performance.

Results: Of the 14,964 women, 201 met the inclusive criteria. SPPH rate was 1.3% overall and 18.9% in women with placenta previa or low-lying placenta. Weight (aOR = 0.93, 95%CI 0.87-0.99), increta or percreta placenta (aOR = 7.93, 95%CI 2.53-24.77) were the risk factors. The area under the ROC curve was 0.69(95%CI 0.59-0.80) for increta or percreta placenta alone, and 0.72(95%CI 0.62-0.82) for the combination of times of cesarean sections and anterior placenta.

Conclusions: Placenta accreta spectrum was the key independent risk factor of SPPH in women with placenta previa or low-lying placenta. Antenatal risk assessment of SPPH in these population is highly desirable and optimal intervention could be planned.

Citing Articles

Abnormal microRNA expression profile at early stages of gestation in pregnancies destined to develop placenta previa.

Hromadnikova I, Kotlabova K, Krofta L Front Med (Lausanne). 2024; 11:1469855.

PMID: 39691371 PMC: 11650449. DOI: 10.3389/fmed.2024.1469855.

References
1.
Chen C, Liu X, Chen D, Huang S, Yan X, Liu H . A risk model to predict severe postpartum hemorrhage in patients with placenta previa: a single-center retrospective study. Ann Palliat Med. 2019; 8(5):611-621. DOI: 10.21037/apm.2019.09.04. View

2.
Cahill A, Beigi R, Heine R, Silver R, Wax J . Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018; 219(6):B2-B16. DOI: 10.1016/j.ajog.2018.09.042. View

3.
Baba Y, Ohkuchi A, Usui R, Suzuki H, Kuwata T, Matsubara S . Calculating probability of requiring allogeneic blood transfusion using three preoperative risk factors on cesarean section for placenta previa. Arch Gynecol Obstet. 2014; 291(2):281-5. DOI: 10.1007/s00404-014-3451-x. View

4.
Liu C, Yu F, Xu Y, Li J, Guan Z, Sun M . Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study. BMC Pregnancy Childbirth. 2021; 21(1):332. PMC: 8077797. DOI: 10.1186/s12884-021-03818-1. View

5.
. [Guidelines for the diagnosis and management of placenta previa (2020)]. Zhonghua Fu Chan Ke Za Zhi. 2020; 55(1):3-8. DOI: 10.3760/cma.j.issn.0529-567X.2020.01.002. View